Timing of cyclosporine administration in patients with delayed graft function

Arthur J. Matas, Vivian A. Tellis, Theresa A. Quinn, Dan Glicklich, Robert Soberman, Frank J. Veith

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cyclosporine in renal transplant recipients with delayed graft function (DGF) has been reported to decrease graft survival and prolong both DGF and hospitalization. In some centers, antilymphocyte globulin (ALG) has been used perioperatively to obviate these problems, but ALG is associated with increased viral infections. In this study, first cadaver transplant recipients with a fall in serum creatinine level of ≥ 30% in the first 24 hr were started on prednisone (P) and cyclosporine (Group 1, n = 18). Those whose creatinine level did not fall were started on P and azathioprine (Group 2, n = 23) and switched to P and cyclosporine when serum creatinine fell 30%. One-year patient survival was 98%. One-year graft survival was 83% for both Groups 1 and 2 (NS). Results were compared to historical controls with DGF who received P and cyclosporine (Group 3, n = 19). Patients with DGF and requiring dialysis had fewer dialyses (P < 0.05) and a shorter hospital stay (P < 0.05) if started on azathioprine, as compared to those started on cyclosporine. Patients with DGF had a higher serum creatinine at 12 months than those with immediate function (P < 0.05). We conclude that withholding cyclosporine until DGF is resolving decreases the duration of dialysis, decreases hospital stay, and without the use of prophylactic ALG, is associated with graft survival equivalent to that in patients with immediate function.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalJournal of Surgical Research
Volume43
Issue number6
DOIs
StatePublished - 1987

Fingerprint

Delayed Graft Function
Cyclosporine
Antilymphocyte Serum
Creatinine
Graft Survival
Azathioprine
Dialysis
Length of Stay
Serum
Virus Diseases
Prednisone
Cadaver
Hospitalization
Kidney
Survival

ASJC Scopus subject areas

  • Surgery

Cite this

Matas, A. J., Tellis, V. A., Quinn, T. A., Glicklich, D., Soberman, R., & Veith, F. J. (1987). Timing of cyclosporine administration in patients with delayed graft function. Journal of Surgical Research, 43(6), 489-494. https://doi.org/10.1016/0022-4804(87)90121-1

Timing of cyclosporine administration in patients with delayed graft function. / Matas, Arthur J.; Tellis, Vivian A.; Quinn, Theresa A.; Glicklich, Dan; Soberman, Robert; Veith, Frank J.

In: Journal of Surgical Research, Vol. 43, No. 6, 1987, p. 489-494.

Research output: Contribution to journalArticle

Matas, AJ, Tellis, VA, Quinn, TA, Glicklich, D, Soberman, R & Veith, FJ 1987, 'Timing of cyclosporine administration in patients with delayed graft function', Journal of Surgical Research, vol. 43, no. 6, pp. 489-494. https://doi.org/10.1016/0022-4804(87)90121-1
Matas, Arthur J. ; Tellis, Vivian A. ; Quinn, Theresa A. ; Glicklich, Dan ; Soberman, Robert ; Veith, Frank J. / Timing of cyclosporine administration in patients with delayed graft function. In: Journal of Surgical Research. 1987 ; Vol. 43, No. 6. pp. 489-494.
@article{782752c48f024bd9a3d6cc499726f987,
title = "Timing of cyclosporine administration in patients with delayed graft function",
abstract = "Cyclosporine in renal transplant recipients with delayed graft function (DGF) has been reported to decrease graft survival and prolong both DGF and hospitalization. In some centers, antilymphocyte globulin (ALG) has been used perioperatively to obviate these problems, but ALG is associated with increased viral infections. In this study, first cadaver transplant recipients with a fall in serum creatinine level of ≥ 30{\%} in the first 24 hr were started on prednisone (P) and cyclosporine (Group 1, n = 18). Those whose creatinine level did not fall were started on P and azathioprine (Group 2, n = 23) and switched to P and cyclosporine when serum creatinine fell 30{\%}. One-year patient survival was 98{\%}. One-year graft survival was 83{\%} for both Groups 1 and 2 (NS). Results were compared to historical controls with DGF who received P and cyclosporine (Group 3, n = 19). Patients with DGF and requiring dialysis had fewer dialyses (P < 0.05) and a shorter hospital stay (P < 0.05) if started on azathioprine, as compared to those started on cyclosporine. Patients with DGF had a higher serum creatinine at 12 months than those with immediate function (P < 0.05). We conclude that withholding cyclosporine until DGF is resolving decreases the duration of dialysis, decreases hospital stay, and without the use of prophylactic ALG, is associated with graft survival equivalent to that in patients with immediate function.",
author = "Matas, {Arthur J.} and Tellis, {Vivian A.} and Quinn, {Theresa A.} and Dan Glicklich and Robert Soberman and Veith, {Frank J.}",
year = "1987",
doi = "10.1016/0022-4804(87)90121-1",
language = "English (US)",
volume = "43",
pages = "489--494",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Timing of cyclosporine administration in patients with delayed graft function

AU - Matas, Arthur J.

AU - Tellis, Vivian A.

AU - Quinn, Theresa A.

AU - Glicklich, Dan

AU - Soberman, Robert

AU - Veith, Frank J.

PY - 1987

Y1 - 1987

N2 - Cyclosporine in renal transplant recipients with delayed graft function (DGF) has been reported to decrease graft survival and prolong both DGF and hospitalization. In some centers, antilymphocyte globulin (ALG) has been used perioperatively to obviate these problems, but ALG is associated with increased viral infections. In this study, first cadaver transplant recipients with a fall in serum creatinine level of ≥ 30% in the first 24 hr were started on prednisone (P) and cyclosporine (Group 1, n = 18). Those whose creatinine level did not fall were started on P and azathioprine (Group 2, n = 23) and switched to P and cyclosporine when serum creatinine fell 30%. One-year patient survival was 98%. One-year graft survival was 83% for both Groups 1 and 2 (NS). Results were compared to historical controls with DGF who received P and cyclosporine (Group 3, n = 19). Patients with DGF and requiring dialysis had fewer dialyses (P < 0.05) and a shorter hospital stay (P < 0.05) if started on azathioprine, as compared to those started on cyclosporine. Patients with DGF had a higher serum creatinine at 12 months than those with immediate function (P < 0.05). We conclude that withholding cyclosporine until DGF is resolving decreases the duration of dialysis, decreases hospital stay, and without the use of prophylactic ALG, is associated with graft survival equivalent to that in patients with immediate function.

AB - Cyclosporine in renal transplant recipients with delayed graft function (DGF) has been reported to decrease graft survival and prolong both DGF and hospitalization. In some centers, antilymphocyte globulin (ALG) has been used perioperatively to obviate these problems, but ALG is associated with increased viral infections. In this study, first cadaver transplant recipients with a fall in serum creatinine level of ≥ 30% in the first 24 hr were started on prednisone (P) and cyclosporine (Group 1, n = 18). Those whose creatinine level did not fall were started on P and azathioprine (Group 2, n = 23) and switched to P and cyclosporine when serum creatinine fell 30%. One-year patient survival was 98%. One-year graft survival was 83% for both Groups 1 and 2 (NS). Results were compared to historical controls with DGF who received P and cyclosporine (Group 3, n = 19). Patients with DGF and requiring dialysis had fewer dialyses (P < 0.05) and a shorter hospital stay (P < 0.05) if started on azathioprine, as compared to those started on cyclosporine. Patients with DGF had a higher serum creatinine at 12 months than those with immediate function (P < 0.05). We conclude that withholding cyclosporine until DGF is resolving decreases the duration of dialysis, decreases hospital stay, and without the use of prophylactic ALG, is associated with graft survival equivalent to that in patients with immediate function.

UR - http://www.scopus.com/inward/record.url?scp=0023547395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023547395&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(87)90121-1

DO - 10.1016/0022-4804(87)90121-1

M3 - Article

VL - 43

SP - 489

EP - 494

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -